US 10899826
Pharmaceutical compositions for an anti-CGRP antagonist antibody
granted A61KA61K39/39591A61K47/183
Quick answer
US patent 10899826 (Pharmaceutical compositions for an anti-CGRP antagonist antibody) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Grant date
- Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 52
- CPC classes
- A61K, A61K39/39591, A61K47/183, A61K47/26, A61K47/34